|
African Crop Science Journal
African Crop Science Society
ISSN: 1021-9730 EISSN: 2072-6589
Vol. 3, Num. 2, 1995, pp. 181-184
|
African Crop Science Journal, Vol. 3. No. 2, pp. 181-184,
1995
Issues, concerns, and strategies in addressing
biosafety
YILMA KEBEDE
Pioneer Hi-Bred Intl. Inc. 7300 N.W. 62nd Avenue P.O. Box 1004
Johnston, IA 950131-1004, USA
Code Number:CS95024
Size of Files:
Text: 13K
No associated graphics files
ABSTRACT
Biotechnology guidelines and policies are essential to creating
public and political confidence, encourage future investment and
reduce fears and scepticism. We need to be aware of technologies
that could be detrimental and encourage those that are
potentially useful. Thus, the over-regulation of the science need
not carry the day but be tempered with caution. Most new
technologies have gone through phases of caution and remain under
regulation, and most technological advancements are not
inherently bad but unanticipated misuse or side effects could
bring many into disrepute. Fear of the unknown has forced us to
evaluate advances in technology for any unintended side effects.
Gatherings, such as this conference on sorghum biosafety, are
important in creating awareness, sorting out issues, and arriving
at some consensus. Countries in the developing world are in the
proccess of developing safety regulations, thus the opportunity
is ripe for coordination and harmonization of regulations. The
International Service for the Acquisition of Agri-Biotech
Applications (ISAAA) is in a unique position to implement this
process through capacity building and information exchange. There
is interest in biotechnology companies in this regard and Pioneer
Overseas Corporation has been contributing to the ISAAA
initiative.
Key Words: Biotechnology guidelines, ISAAA. sorghum
RESUME
Les lignes directrices et les politiques de biotechnologie
sont essentielles pour creer une confiance publique et politique,
encourager des investissements futurs et reduire la peur et le
scepticisme. Il est bon de connaitre les technologies qui peuvent
s'averer nuisibles et celles qui sont potentiellement utiles afin
de les utiliser avec prudence. La plupart de technologies ont
depasse la phase d'utilisation avec prudence; elles sont sous
controlees et les plus avancees ne sont pas necessairement
mauvaises saul en cas de mauvaise utilisation occasionnant des
effets secondaires indesirables. Les reunions telles que cette
conference sur la biosecurite du sorgho sont des occasions de
sensibilisation pour discuter du probleme et arriver a un
consensus. Comme les pays en voie de developpement sont dans le
processus de mise en place de reglements de biosecurite, le
moment est donc propice pour coordonner et harmoniser les
reglements. Le service International d'Aquisition des
Applications de l'Agrobiotechnologie (ISAAA) est tres bien place
pour realiser ce processus par le developpement de sa capacite
et l'echange d'information. A cet egard, compagnies de
biotechnologies et les corporations pionieres etrangeres ont
commence a contribuer l'initiative de l'ISAAA.
Mots Cles: Lignes directrices de biotechnologie, ISAAA,
sorgho
INTRODUCTION
The improvement in crop performance involves a host of factors
(physical, biological, social, economic). Plant breeding has
played a key role in delivering improved cultivars to farmers,
the agroindustry and consumers. Biotechnology is proving to be
a promising tool for effective plant selection and understanding
of mechanisms for plant improvement. A number of possibilities
are being pursued among which the following hold promise:
tolerance to low rate usage herbicides, resistance to problem
pests (toxicity), resistance to viral infection, added value
(starch, oil content, amino acids), and enhancing breeding
methods (choice of parents, marker assisted selection).
There is a growing interest in establishing programmes to
integrate biotechnology with traditional plant breeding. The
concern is not whether or when the technology will work but with
other non-biological issues which affect the future of
genetically engineered plants. Such issues include: biosafety-
regulatory approval for field testing, risks involved, and
timeline for commercialization; proprietary protection-risks and
rewards, return on investment; public knowledge-proper awareness;
and finance research support (Gosser and Fraley, 1989).
The growing interest and awareness in biotechnology is best
exemplified by the increased use of the prefix bio- with many
words (.e.g. biodiversity, biopesticides, biofertilizers, even
biodiplomacy, bio-piracy, bio-bucks and bio-policy). Our concern
here lies in biosafety where regulations concerning testing and
transfer have become a prerequisite. Some of the issues, risks
and strategies to address the condition will be discussed. In
order to get an overall picture of biosafety we will need to
consider the major players against a background of the issues.
risks and strategies. The major players are: (1) technology
generators (seed industry, National Agriculture Research Systems
(NARS) and International Agriculture Research Centres (IARCs),
(2) technology users (NARS, farmers), and (3) regulatory bodies
(national, regional and international).
ISSUES
Recent advances in biotechnology have created new
opportunities for efficient crop improvement and added value to
new varieties/hybrids. The process has necessitated caution to
avoid any unforeseen problems. However, perceived problems should
not unjustly prejudice a technique that holds promise.
As much as technology generators (especially the seed
industry) are aware of the situation, the need for timely
commercialization of a new technology to keep market share and
return on investment ~s also an important issue. However, the
need to convert laboratory and small scale trials to wide area
commercial tests where resources are expensive also requires
establishment of a framework of agreed scientific principles of
safety and trial conduct.
Users, on the other hand, prefer the latest technologies to
improve earnings. At the same time, they need assurance of safety
that agriculture and the environment are adequately protected.
Regulatory bodies are required to harmonize these concerns and
to realize that wide area testing and obtaining data in a timely
and cost effective manner without compromising safety is of
paramount importance.
RISKS
Delays in testing and approval could jeopardize investment
in research and could result in the loss of a competitive edge
and customers. Consumers could be deprived of potential benefits
from crops with improved agronomic performance and fewer chemical
requirements. On the other hand, there could be undesirable
effects in the absence of adequate monitoring and guidelines.
Regulatory bodies' or guidelines could be restrictive and
bureaucratic which could further be compounded by scarcity of
finance and personnel to review and monitor trials. There could
also be conflicts of interest in monitoring products which they
have helped develop.
STRATEGIES
Foremost for researchers is the need for providing sufficient
precaution for containment. Researchers should have an improved
understanding of factors that impact biotechnology product
transfer to undertake a proper risk assessment. Notification of
regulatory authorities of intent and educating the public,
opinion leaders and the media would also be essential.
The technology user should be involved in providing feedback
and voicing concern. Emphasis on capacity building and further
linkages with organizations such as IARCs. International Service
for the Acquisition of Agri-biotech Applications (ISAAA). United
States Department of Agriculture (USDA) and ABSP would help in
understanding products.
The regulatory mechanism should be based on risks. The
mechanism, should provide guidelines and adequate oversight with
enough flexibility in reviewing research protocol. In essence.
the regulatory mechanism should create an enabling environment
that will stimulate rather than discourage the transfer of
technology.
INDUSTRY PERSPECTIVE
The major portion of research relies on traditional plant
breeding with biotechnology (focused on plant transformation )
expected to have a significant role for future products. Among
the goals that have been established at Pioneer Hi-Bred
International for Research and Product Development (Anon.1994).
the following are relevant to this workshop: (1) use new
technologies to augment current crop improvement methods and
transfer non-traditional traits into commercial products, and (2)
vigorously protect intellectual property, comply with regulatory
requirements and follow responsible environmental practices.
At present Pioneer Overseas Corporation is working on
transforming some of its major crops in its own laboratories or
in research partnerships. There is a considerable amount of time
and money spent in understanding the whole transformation
process. Stable transformation will enable Pioneer Overseas
Corporation to put desirable traits directly into plant ceils.
This achievement will shorten time for developing new products
and give Pioneer Overseas Corporation the ability to offer
products with new traits not possible through traditional plant
breeding techniques.
BIOSAFETY
In dealing with biosafety, the question is not how we can
reduce the potential risk. but what the relative risks of the new
technologies are compared with the technologies which they
replace (Persley et al., 1993). In addressing the question
of safety in its biotechnology development programmes, Pioneer
Overseas Corporation
(a) has established an institutional biosafety committee;
(b) has traditionally supported the development of regulatory
oversight of research and development of the products of
biotechnology;
(c) has endorsed the system implemented by USDA-APHIS. i.e..
notification of regulatory authorities of intent to conduct
tests and provide information on methods of containment:
(d) supports the implementation of systems to fast track
applications where trials are a repetition of previously
known trials or those that conform to acceptable containment
standards and
(e) does not feel that biotechnology poses an entirely new set
of safety issues (Townsend, 1994).
FRAMEWORK FOR ANALYSIS
Safety guidelines should recognize economic interests and
ecological requirements. Thus, there is a need to develop some
framework for identifying the issues involved in dealing with the
major aspects of biosafety as it relates to testing and transfer.
This in turn will help us assess the different protocols. Some
of the guidelines are highlighted below.
Containment. Physical and biological isolation.
Familiarity. Having enough information or experience on
the organism, target environment and interactions to judge
safety, and also recognizing that some biotechnology derived
products will be comparable to traditionally developed
products.
Risk/Benefit. Assessment through field trial and
recognizing the precision of the development of the technology.
Pesticides may not be risk free but have had a net beneficial
effect.
Demand. Consider need and priority of the technology; i.e.
user/market requirement, for example, herbicide resistance vs
Striga resistance.
Institutional Environment. Developers of the technology,
users of the technology (level of technology), experiences
elsewhere.
Through better definition of these issues, this framework can
provide a tool to gauge safety and ensure that future development
efforts are not unduly prejudiced.
REFERENCES
Anon. 1994. Annual Report. Pioneer Hi-Bred
International Incroporated, Des Moines, IA, USA.
Gosser, C.S. and Fraley, R. 1989. Genetically engineering plants
for crop improvement. Science 244:1293-1295.
Persley, G.J., Graddings, L.V. and Juma, C. 1993. Biosafety - The
safe application of biotechnology in agriculture and the
environment. Research Report No. 5, ISNAR, The Hague.
Townsend, R. 1994. Pioneer Hi-Bred's perspective on field testing
of transgenic maize. In: Biosafety for Sustainable
Agriculture. Sharing Biotechnology Regulators' Experience of the
Western Hemisphere. Krattiger, A.F. and Rosemarin, A.
(Eds.), pp. 181-190. ISAAA; Ithaca & SEI: Stockholm.
Copyright 1995 African Crop Science Society
|